Increase/Decrease in Cash: The total change in cash for the company over the given period.
Regentis Biomaterials Ltd. (RGNT) had Increase/Decrease in Cash of $7.15M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$7.62M |
|
-- |
|
-- |
|
$7.62M |
|
$2.87M |
|
-- |
|
-- |
|
$2.87M |
|
$4.74M |
|
$4.74M |
|
$4.74M |
|
-- |
|
| Cash Flow Statement Financials | |
$-1.38M |
|
$0.00M |
|
$8.52M |
|
$0.23M |
|
$7.38M |
|
|
Increase/Decrease in Cash |
$7.15M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|